Literature DB >> 19894430

Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Suzanne F Beavers1, David B Blossom, Timothy L Wiemken, Kelly Y Kawaoka, Andrew Wong, Linda Goss, Malkanthie I McCormick, Douglas Thoroughman, Arjun Srinivasan.   

Abstract

OBJECTIVES: Acinetobacter baumannii (A. baumannii) is a well-described cause of nosocomial outbreaks and can be highly resistant to antimicrobials. We investigated A. baumannii outbreaks at two Kentucky hospitals to find risk factors for Acinetobacter acquisition in hospitalized patients.
METHODS: We performed case-control studies at both hospitals. We defined a case as a clinical culture growing A. baumannii from a patient from August 1 to October 31, 2006 (Hospital A), or April 1 to October 31, 2006 (Hospital B).
RESULTS: Twenty-nine cases were identified at Hospital A and 72 cases were identified at Hospital B. The median case patient age was 42 years in Hospital A and 46 years in Hospital B. The majority of positive cultures were from sputum (Hospital A, 51.7%; Hospital B, 62.5%). The majority of case patients had multidrug-resistant A. baumannii (Hospital A, 75.9%; Hospital B, 70.8%). Using logistic regression, controlling for age and admitting location, mechanical ventilation (Hospital A odds ratio [OR] = 21.6; 95% confidence interval [CI] 3.5, 265.9; Hospital B OR = 4.5, 95% CI 1.9, 11.1) was associated with A. baumannii recovery. Presence of a nonsurgical wound (OR = 6.6, 95% CI 1.2, 50.8) was associated with recovery of A. baumannii at Hospital A.
CONCLUSIONS: We identified similar patient characteristics and risk factors for A. baumannii acquisition at both hospitals. Our findings necessitate the importance of review of infection control procedures related to respiratory therapy and wound care.

Entities:  

Mesh:

Year:  2009        PMID: 19894430      PMCID: PMC2773951          DOI: 10.1177/003335490912400615

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  22 in total

1.  Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary intensive care unit.

Authors:  D C Sofianou; T C Constandinidis; M Yannacou; H Anastasiou; E Sofianos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-06       Impact factor: 3.267

2.  Infrequent isolation of multiresistant Acinetobacter baumannii from the staff tending a colonized patient with severe burns.

Authors:  T Paavilainen; M Alanen; M Mäkelä; M Routamaa; H Järvinen; P Huovinen; P Kotilainen
Journal:  Infect Control Hosp Epidemiol       Date:  2001-06       Impact factor: 3.254

3.  Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital.

Authors:  Claudester Stephens; Stephen J Francis; Virginia Abell; Joseph R DiPersio; Patricia Wells
Journal:  Am J Infect Control       Date:  2007-05       Impact factor: 2.918

4.  Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis.

Authors:  Yhu-Chering Huang; Lin-Hui Su; Tsu-Lan Wu; Hsieh-Shong Leu; Wu-Shiun Hsieh; Tung-Mei Chang; Tzou-Yien Lin
Journal:  Pediatr Infect Dis J       Date:  2002-12       Impact factor: 2.129

5.  Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit.

Authors:  A S Levin; S Gobara; C M Mendes; M R Cursino; S Sinto
Journal:  Infect Control Hosp Epidemiol       Date:  2001-11       Impact factor: 3.254

6.  Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.

Authors:  J M Boyce; G Potter-Bynoe; C Chenevert; T King
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

7.  Survival of Acinetobacter baumannii on dry surfaces.

Authors:  C Wendt; B Dietze; E Dietz; H Rüden
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

8.  Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.

Authors:  H Wisplinghoff; M B Edmond; M A Pfaller; R N Jones; R P Wenzel; H Seifert
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

Review 9.  Acinetobacter outbreaks, 1977-2000.

Authors:  Maria Virginia Villegas; Alan I Hartstein
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

10.  Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit.

Authors:  S S El Shafie; M Alishaq; M Leni Garcia
Journal:  J Hosp Infect       Date:  2004-02       Impact factor: 3.926

View more
  4 in total

1.  Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model.

Authors:  Elizabeth J Brisbois; Jill Bayliss; Jianfeng Wu; Terry C Major; Chuanwu Xi; Stewart C Wang; Robert H Bartlett; Hitesh Handa; Mark E Meyerhoff
Journal:  Acta Biomater       Date:  2014-06-28       Impact factor: 8.947

2.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

3.  Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility.

Authors:  Christin N McQueary; Benjamin C Kirkup; Yuanzheng Si; Miriam Barlow; Luis A Actis; David W Craft; Daniel V Zurawski
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

4.  Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Authors:  Guanpingshen Luo; Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Paul Pantapalangkoor; Robert A Bonomo; Yohei Doi; Mark D Adams; Thomas A Russo; Brad Spellberg
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.